News
05-29-2015, 04:11 AM
Array BioPharma Inc. today announced presentations on encorafenib, binimetinib and selumetinib (licensed to AstraZeneca) at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 29 – June 2, 2015 in Chicago, Illinois.
More... (http://www.news-medical.net/news/20150529/Array-BioPharma-presents-clinical-data-of-BRAF-MEK-and-HER2-drugs-at-2015-ASCO-Annual-Meeting.aspx)
More... (http://www.news-medical.net/news/20150529/Array-BioPharma-presents-clinical-data-of-BRAF-MEK-and-HER2-drugs-at-2015-ASCO-Annual-Meeting.aspx)